Vol. 13, Issue 2, 2006January 01, 2006 EDT
Access to the Safe Harbor: Bioterrorism, Influenza, and the Supreme Court’s Interpretation of the Research Exemption From Patent Infringement
Access to the Safe Harbor: Bioterrorism, Influenza, and the Supreme Court’s Interpretation of the Research Exemption From Patent Infringement
Michael J. Brignati, Journal of Intellectual Property,
Merck KGaA v. Integra LifeSciencesILtd.Hatch-Waxman Actinvestigational new drugbiological innovation for open societytropical disease initiativeManhattan ProjectPandemic Influenza Preparations and ResponseMadey v. Duke Universitypatent doctrineexperimental use exemptionwhittemore v. cuttersawin v. guildembrexinc. v. service engineering corp.Bayh-Dole Act of 1980roche productsinc. v. bolar pharmaceuticals co.drug price competition and patent term restoration actpatented inventionreasonably relatedeli lilly & Co. v. MedtronicInc.amgenInc. v. hoechst marion rousselinc.
Michael J. Brignati & Journal of Intellectual Property, Access to the Safe Harbor: Bioterrorism, Influenza, and the Supreme Court’s Interpretation of the Research Exemption From Patent Infringement, 13 Journal of Intellectual Property 375 (2006).